Thrivent Financial for Lutherans’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-37,636	Closed	-$2.47M	–	2497
2025 Q2	$2.47M	Buy	37,636 +1,701	+5%	+$111K	0.01%	1217
2025 Q1	$2.54M	Buy	35,935 +2,019	+6%	+$140K	0.01%	1129
2024 Q4	$2.23M	Buy	33,916 +1,407	+4%	+$96.8K	﹤0.01%	1350
2024 Q3	$2.29M	Buy	32,509 +6,214	+24%	+$433K	﹤0.01%	1349
2024 Q2	$1.74M	Buy	26,295 +2,272	+9%	+$149K	﹤0.01%	1472
2024 Q1	$1.63M	Buy	24,023 +2,672	+13%	+$177K	﹤0.01%	1567
2023 Q4	$1.32M	Buy	21,351 +5,556	+35%	+$327K	﹤0.01%	1666
2023 Q3	$932K	Buy	15,795 +3,510	+29%	+$215K	﹤0.01%	1788
2023 Q2	$733K	Buy	12,285 +936	+8%	+$55.6K	﹤0.01%	1997
2023 Q1	$663K	Buy	11,349 +1,425	+14%	+$85.8K	﹤0.01%	2008
2022 Q4	$616K	Buy	9,924 +603	+6%	+$36.3K	﹤0.01%	2019
2022 Q3	$527K	Buy	9,321 +378	+4%	+$23.3K	﹤0.01%	2052
2022 Q2	$571K	Sell	8,943 -1,857	-17%	-$118K	﹤0.01%	2028
2022 Q1	$699K	Buy	+10,800	New	+$685K	﹤0.01%	2030